AGE VERIFICATION

Please certify that you are 19 of age or older in order to access this website.

Yes, I am over 19 No, I am under 19

Latest News/Research

energy micro dosing Psychedelic microdosing. Magic shroom . Medicines physical Dry Psilocybe cubensis. Psilocybin mushroom.
Press BriefResearch Summary

Queen’s and KHSC launch clinical trial of psilocybin therapy to treat alcohol use disorder

Queen's University and Kingston Health Sciences Centre have launched a clinical trial to investigate psilocybin-assisted therapy for alcohol use disorder (AUD). The study aims to explore the safety, efficacy, and feasibility of this novel treatment approach, building on the growing body of research suggesting potential therapeutic benefits of psychedelic substances for various mental health conditions.
by The ShrumLane Team April 26, 2023
Psychedelic psilocybin mushrooms Golden Teacher on mycelium block, close-up. Psilocybe Cubensis raw mushrooms isolated on white background. Micro-dosing concept.
Press BriefResearch Summary

Pain, hope, and science collide as athletes turn to magic mushrooms

More athletes are exploring magic mushrooms, with psilocybin, for addressing physical pain, mental health issues, and performance improvement. While there are anecdotal claims and growing research supporting the potential benefits of psychedelics, additional studies are necessary to confirm their safety and efficacy in sports. It's crucial to weigh potential advantages against risks, promoting responsible use through education and harm reduction strategies.
by The ShrumLane Team April 25, 2023
Psychedelic psilocybin mushrooms Golden Teacher on mycelium block, close-up. Psilocybe Cubensis raw mushrooms isolated on white background. Micro-dosing concept.
Press BriefResearch Summary

Psychedelics May Better Treat Depression and Anxiety Symptoms than Prescription Antidepressants for Patients with Advanced Cancer

A study found that psychedelics, such as psilocybin and MDMA, may be more effective than antidepressants in treating depression and anxiety in patients with advanced cancer. The effects were rapid and long-lasting, with few side effects. Further research is needed to confirm the findings and establish the safety and efficacy of this treatment.
by The ShrumLane Team April 22, 2023
Glass jar on white background. Psychedelic, magic mushroom. Medical usage, wellbeing.
Research Summary

Psilocybin Promising for Body Dysmorphic Disorder

A pilot study has demonstrated promising results for psilocybin-assisted psychotherapy in treating body dysmorphic disorder (BDD). Participants experienced significant reductions in BDD symptom severity, depression, anxiety, and suicidal ideation. However, further research, including randomized controlled trials, is needed to confirm these findings and establish the safety and efficacy of this treatment approach.
by The ShrumLane Team April 19, 2023
12-month follow-up 1 5-HT2A receptor 2 abstinence rates 1 acute effects 1 addiction 3 addiction treatment 1 advanced cancer 1 adverse effects/events/reactions 3 alcohol consumption 1 Alcohol Use Disorder (AUD) 4 alternative medications 1 alternative treatment 1 antidepressants 3 anxiety 18 athletes 1 attitudes 1 attitudes towards death 1 ayahuasca 1 bad trips 1 bipolar disorder 1 body dysmorphic disorder (BDD) 1 body mass index (BMI) 1 brain network connectivity 1 breakthrough therapy 4 cancer patients 4 clinical applications 1 clinical environment 1 clinical trial 2 clinical trials 4 clinically meaningful response 1 cluster headache 1 co-occurring disorders 1 cognitive functioning 1 cognitive-behavioral therapy (CBT) 3 commodification 1 connectedness 1 controlled trial 1 courses 1 decriminalization 1 default mode network 1 dependence 1 depression 17 depression severity 1 depressive symptoms 0 DMT 1 double-blind 5 efficacy 4 emotional challenges 1 emotional eating 1 emotional release 1 emotional well-being 1 empathy 2 end-of-life care 1 ethical implications 1 existential distress 2 food addiction 1 functioning 1 guide 2 guided trip 1 hallucinogen persisting perception disorder (HPPD) 1 hallucinogenic mushrooms 1 Hamilton Depression Rating Scale 2 harm potential 1 harm reduction 1 headache frequency 1 headache intensity 1 healing process 1 heavy drinking days 1 history 1 implementing insights 1 improved mood 1 indigenous cultures 1 individual differences 1 individual factors 1 interconnectedness 1 international survey 0 introspection 1 Jamaica 1 lasting antidepressant effect 1 legal barriers 1 legal hurdles 1 legalization 1 life-threatening cancer 1 limitations 3 long COVID 1 long-term effects 1 low-dose pulse regimen 1 LSD 3 magic mushrooms 7 mainstream healthcare 1 major depression 1 major depression disorder 1 major depressive disorder (MDD) 7 manic episodes 0 manic symptoms 1 MDMA 3 meaning response 1 mechanism of action 1 mental health 10 mental health treatment 2 meta-analysis 3 microdosing 2 Moms on Mushrooms 1 Montgomery-Asberg Depression Rating Scale (MADRS) 2 mood regulation 0 mycotherapy 1 Netherlands 1 neurobiological mechanisms 0 neuroplasticity 6 nonrandomized controlled trial 1 novel treatment 1 obesity 1 obsessive-compulsive disorder (OCD) 2 online community 1 openness 1 paranoia 1 participant experiences 1 performance enhancement 1 personal experience 2 personal growth 2 pharmacotherapy 2 physical pain 1 physiological responses 1 pilot study 1 placebo-controlled 4 post-traumatic stress disorder (PTSD) 7 potential risks 1 psilocybin 25 Psilocybin therapy 2 psilocybin truffle retreat 1 psilocybin-assisted psychotherapy 1 psilocybin-assisted therapy 16 psychedelic integration 1 psychedelic research 1 psychedelic-assisted therapy 3 psychedelics 6 psychiatric disorders 1 psychiatric illness 1 psycho-social-spiritual well-being 2 psychological distress 1 psychological flexibility 1 psychological growth 1 psychological responses 1 psychotherapists 1 psychotherapy 6 qualitative analysis 2 quality of life 7 randomized 1 randomized controlled trial 8 rapport 2 regulatory barriers/challenges 2 relationships 1 remission 1 research 2 research implications 1 resilience 1 resistance 1 retreat setting 1 risks 5 safety 8 scalable model 1 scientific research 1 self-awareness 1 self-reflection 1 self-report 0 serotonergic system 2 serotonin 2A receptors 1 serotonin agonist 1 set and setting 1 severe depression 1 side effects 3 single-dose 1 social challenges 1 spiritual experiences 3 spiritual well-being 2 standardized treatment protocols 1 stress 1 stress-induced weight gain 1 structured support 1 substance 1 substance use disorders 2 suicidality 1 survey 1 symptom reduction 1 systematic review 1 thematic analysis 1 therapeutic outcomes 2 therapeutic potential/benefits 7 therapeutic relationship 2 therapeutic settings/environment 2 toxicity 1 training 1 transformative experiences 2 treatment 1 treatment efficacy 3 treatment option 1 treatment-resistant depression 4 vulnerable populations 1 web-based questionnaire 0 wellness 1 Yale-Brown Obsessive Compulsive Scale 1
Home
Shop
0 Wishlist
Search
More
More